This study is a special drug use surveillance to evaluate the safety and efficacy of Entresto Tablets (hereafter called Entresto) clinically administered in Japanese patients for the newly approved indication of chronic heart failure and to be conducted as one of the RMP-specified additional pharmacovigilance activities.
This is a single arm, multicenter, observational study in Japanese chronic heart failure patients.